Carmichael Engineering’s unwavering commitment to excellence and expertise in thermal formulation technologies played a pivotal role in accelerating the finishing touch of the HVAC project, aligning perfectly with Lophos’ strategic goals.
“We express our sincere thanks to Carmichael Engineering for their remarkable contribution to the acceleration of the HVAC project, which resulted in the success of our construction in Napanee,” said Claire Stawnyczy, CEO of Lophos. “Their professionalism and determination have been instrumental in advancing our operational goals and strengthening our presence in the region. “
Once construction is occupied, Lophos is about to begin cultivation operations at the facility, which will culminate in the planting of more than 3,000 seeds of Lophophora williamsii (peyote). This expansion marks significant construction from the initially planned 1,000 factories to completion. of 2024, reflecting the company’s ambitious expansion strategy. Taking advantage of the site’s Controlled Substances Reseller License (CSDL), which authorizes the possession, sale, transportation, and delivery of controlled substances, adding mescaline, psilocin, psilocybin, LSD, DMT, MDMA, and ketamine, control believes the company is poised for significant expansion and innovation in the life sciences sector.
Lophos reaffirms its commitment to transparency and innovation, inviting stakeholders to the company’s online page on lophos. com and updates on Twitter (@lophospharma) and LinkedIn.
About LophosLophos Pharmaceuticals Corp. , a wholly-owned subsidiary of Lophos Holdings Inc. (CSE:MESC), is a leading biosciences company specializing in the cultivation, studies and sale of peyote. With a full Controlled Substance Reseller (CSDL) license, the subsidiary is legal to possess, sell, transport, and deliver controlled substances, highlighting the scope of its operations.
For information
Contact:
The Canadian Securities Exchange has neither approved nor disapproved of the contents of this press release and assumes no responsibility for the adequacy or accuracy of this press release.
precaution
Neither the Canadian Securities Exchange nor its Regulatory Service Provider has reviewed or accepted the adequacy or accuracy of this release.
This press release comprises “forward-looking data” within the meaning of applicable Canadian securities legislation. These statements relate to long-term occasions or long-term performance. The use of any of the words “possibly”, “intend”, “expect”, “believe”, “project”, “estimate” and similar expressions and statements relating to matters that are not past facts are intended to identify data forward-looking and are based on Lophos’ existing ideals or assumptions as to the ultimate results and timing of such long-term events. Forward-looking data contained in this press release includes data relating to the progression of the Company’s peyote cactus products. Forward-looking data is based on conservative assumptions made by Lophos as of the data date and is subject to known and unknown risks, uncertainties and other matters that could cause actual effects or events to differ materially. than expected in the report. prospective data. Given these risks, uncertainties and assumptions, you should not place undue reliance on such forward-looking statements. The forward-looking data contained in this press release is made as of the date hereof, and Lophos undertakes no legal responsibility to update or revise such forward-looking data, whether as a result of new data, long-term occasions or otherwise. , as necessary. through applicable securities laws. The foregoing statements expressly qualify any forward-looking information contained herein. Factors that could also cause actual effects to differ materially from those anticipated in such forward-looking statements are described under the heading “Risk Factors” in Lophos’ final detailed prospectus dated August 11, 2023, located at company website. profile. Lophos at www. sedarplus. ArrayCalifornia.